Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single‐centre case series

Graft failure affects approximately 5% of allogeneic stem cell transplants, with a poor prognosis. Salvage second allogeneic stem cell transplantation (alloSCT2) is limited by high rates of transplant‐related mortality from infection and graft‐versus‐host disease. We report on five adult patients re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal medicine journal 2018-08, Vol.48 (8), p.988-991
Hauptverfasser: Kliman, David, Bilmon, Ian, Kwan, John, Blyth, Emily, Micklethwaite, Ken, Panicker, Shyam, Bhattacharyya, Abir, Deren, Stephanie, Antonenas, Vicki, Huang, Gillian, Gottlieb, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 991
container_issue 8
container_start_page 988
container_title Internal medicine journal
container_volume 48
creator Kliman, David
Bilmon, Ian
Kwan, John
Blyth, Emily
Micklethwaite, Ken
Panicker, Shyam
Bhattacharyya, Abir
Deren, Stephanie
Antonenas, Vicki
Huang, Gillian
Gottlieb, David
description Graft failure affects approximately 5% of allogeneic stem cell transplants, with a poor prognosis. Salvage second allogeneic stem cell transplantation (alloSCT2) is limited by high rates of transplant‐related mortality from infection and graft‐versus‐host disease. We report on five adult patients receiving rescue alloSCT2 using haploidentical peripheral blood stem cells. All patients achieved neutrophil engraftment, two subsequently died from sepsis and disease relapse, respectively. Three patients remain alive up to 2 years post‐transplant. We suggest consideration of haploidentical alloSCT2 for patients with graft failure.
doi_str_mv 10.1111/imj.13979
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2092537729</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2084620781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2439-a714983975fe1868add9fedcba25b0aa115e3f423585707b76bab3d74868d30b3</originalsourceid><addsrcrecordid>eNp1kctKxTAQhoMo3he-gATc6KKepElPGnciXo4ogui6TNup5pA2NWkRdz6Cz-iTGD3qQjCbGciXj8z8hOxwdsjjmZh2fsiFVnqJrHMpsyTTWi5_9TJhmok1shHCnDGuhJarZE0wLoTO1Tp5vsVQjUgfobfO1NgNpgJLe_Smf0Qf29I6V9MwYEsrtJYOHrrQW-gGGIzraOM8xe7BQzO08TltwNjR4xEFGkz3YPH99a2KFx5pBQFpiGoMW2SlARtw-7tukvuz07uTi-Tq5nx2cnyVVKkUOgHFpc7jaFmDPJ_mUNe6wboqIc1KBsB5hqKRqcjyTDFVqmkJpaiVjGwtWCk2yf7C23v3NGIYitaEzzmgQzeGImU6zYRSqY7o3h907kbfxd9FKpfTlKmcR-pgQVXeheCxKXpvWvAvBWfFZxpFTKP4SiOyu9_GsWyx_iV_1h-ByQJ4NhZf_jcVs-vLhfIDuAmWOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2084620781</pqid></control><display><type>article</type><title>Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single‐centre case series</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Kliman, David ; Bilmon, Ian ; Kwan, John ; Blyth, Emily ; Micklethwaite, Ken ; Panicker, Shyam ; Bhattacharyya, Abir ; Deren, Stephanie ; Antonenas, Vicki ; Huang, Gillian ; Gottlieb, David</creator><creatorcontrib>Kliman, David ; Bilmon, Ian ; Kwan, John ; Blyth, Emily ; Micklethwaite, Ken ; Panicker, Shyam ; Bhattacharyya, Abir ; Deren, Stephanie ; Antonenas, Vicki ; Huang, Gillian ; Gottlieb, David</creatorcontrib><description>Graft failure affects approximately 5% of allogeneic stem cell transplants, with a poor prognosis. Salvage second allogeneic stem cell transplantation (alloSCT2) is limited by high rates of transplant‐related mortality from infection and graft‐versus‐host disease. We report on five adult patients receiving rescue alloSCT2 using haploidentical peripheral blood stem cells. All patients achieved neutrophil engraftment, two subsequently died from sepsis and disease relapse, respectively. Three patients remain alive up to 2 years post‐transplant. We suggest consideration of haploidentical alloSCT2 for patients with graft failure.</description><identifier>ISSN: 1444-0903</identifier><identifier>EISSN: 1445-5994</identifier><identifier>DOI: 10.1111/imj.13979</identifier><identifier>PMID: 30133987</identifier><language>eng</language><publisher>Melbourne: John Wiley &amp; Sons Australia, Ltd</publisher><subject>Adult ; allogeneic stem cell transplant ; Female ; graft failure ; Graft rejection ; Graft Rejection - diagnosis ; Graft Rejection - therapy ; Graft Survival - physiology ; Grafts ; graft‐versus‐host disease ; haploidentical transplant ; Hematopoietic stem cells ; Humans ; Male ; Middle Aged ; Peripheral blood ; Peripheral Blood Stem Cell Transplantation - methods ; Peripheral Blood Stem Cell Transplantation - trends ; peripheral blood stem cells ; Salvage Therapy - methods ; Salvage Therapy - trends ; Sepsis ; Stem cell transplantation ; Stem cells ; Transplantation, Haploidentical - methods ; Transplantation, Haploidentical - trends ; Transplants &amp; implants ; Treatment Failure ; Young Adult</subject><ispartof>Internal medicine journal, 2018-08, Vol.48 (8), p.988-991</ispartof><rights>2018 Royal Australasian College of Physicians</rights><rights>2018 Royal Australasian College of Physicians.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2439-a714983975fe1868add9fedcba25b0aa115e3f423585707b76bab3d74868d30b3</cites><orcidid>0000-0002-2020-0275</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fimj.13979$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fimj.13979$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30133987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kliman, David</creatorcontrib><creatorcontrib>Bilmon, Ian</creatorcontrib><creatorcontrib>Kwan, John</creatorcontrib><creatorcontrib>Blyth, Emily</creatorcontrib><creatorcontrib>Micklethwaite, Ken</creatorcontrib><creatorcontrib>Panicker, Shyam</creatorcontrib><creatorcontrib>Bhattacharyya, Abir</creatorcontrib><creatorcontrib>Deren, Stephanie</creatorcontrib><creatorcontrib>Antonenas, Vicki</creatorcontrib><creatorcontrib>Huang, Gillian</creatorcontrib><creatorcontrib>Gottlieb, David</creatorcontrib><title>Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single‐centre case series</title><title>Internal medicine journal</title><addtitle>Intern Med J</addtitle><description>Graft failure affects approximately 5% of allogeneic stem cell transplants, with a poor prognosis. Salvage second allogeneic stem cell transplantation (alloSCT2) is limited by high rates of transplant‐related mortality from infection and graft‐versus‐host disease. We report on five adult patients receiving rescue alloSCT2 using haploidentical peripheral blood stem cells. All patients achieved neutrophil engraftment, two subsequently died from sepsis and disease relapse, respectively. Three patients remain alive up to 2 years post‐transplant. We suggest consideration of haploidentical alloSCT2 for patients with graft failure.</description><subject>Adult</subject><subject>allogeneic stem cell transplant</subject><subject>Female</subject><subject>graft failure</subject><subject>Graft rejection</subject><subject>Graft Rejection - diagnosis</subject><subject>Graft Rejection - therapy</subject><subject>Graft Survival - physiology</subject><subject>Grafts</subject><subject>graft‐versus‐host disease</subject><subject>haploidentical transplant</subject><subject>Hematopoietic stem cells</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Peripheral blood</subject><subject>Peripheral Blood Stem Cell Transplantation - methods</subject><subject>Peripheral Blood Stem Cell Transplantation - trends</subject><subject>peripheral blood stem cells</subject><subject>Salvage Therapy - methods</subject><subject>Salvage Therapy - trends</subject><subject>Sepsis</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Transplantation, Haploidentical - methods</subject><subject>Transplantation, Haploidentical - trends</subject><subject>Transplants &amp; implants</subject><subject>Treatment Failure</subject><subject>Young Adult</subject><issn>1444-0903</issn><issn>1445-5994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kctKxTAQhoMo3he-gATc6KKepElPGnciXo4ogui6TNup5pA2NWkRdz6Cz-iTGD3qQjCbGciXj8z8hOxwdsjjmZh2fsiFVnqJrHMpsyTTWi5_9TJhmok1shHCnDGuhJarZE0wLoTO1Tp5vsVQjUgfobfO1NgNpgJLe_Smf0Qf29I6V9MwYEsrtJYOHrrQW-gGGIzraOM8xe7BQzO08TltwNjR4xEFGkz3YPH99a2KFx5pBQFpiGoMW2SlARtw-7tukvuz07uTi-Tq5nx2cnyVVKkUOgHFpc7jaFmDPJ_mUNe6wboqIc1KBsB5hqKRqcjyTDFVqmkJpaiVjGwtWCk2yf7C23v3NGIYitaEzzmgQzeGImU6zYRSqY7o3h907kbfxd9FKpfTlKmcR-pgQVXeheCxKXpvWvAvBWfFZxpFTKP4SiOyu9_GsWyx_iV_1h-ByQJ4NhZf_jcVs-vLhfIDuAmWOg</recordid><startdate>201808</startdate><enddate>201808</enddate><creator>Kliman, David</creator><creator>Bilmon, Ian</creator><creator>Kwan, John</creator><creator>Blyth, Emily</creator><creator>Micklethwaite, Ken</creator><creator>Panicker, Shyam</creator><creator>Bhattacharyya, Abir</creator><creator>Deren, Stephanie</creator><creator>Antonenas, Vicki</creator><creator>Huang, Gillian</creator><creator>Gottlieb, David</creator><general>John Wiley &amp; Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2020-0275</orcidid></search><sort><creationdate>201808</creationdate><title>Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single‐centre case series</title><author>Kliman, David ; Bilmon, Ian ; Kwan, John ; Blyth, Emily ; Micklethwaite, Ken ; Panicker, Shyam ; Bhattacharyya, Abir ; Deren, Stephanie ; Antonenas, Vicki ; Huang, Gillian ; Gottlieb, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2439-a714983975fe1868add9fedcba25b0aa115e3f423585707b76bab3d74868d30b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>allogeneic stem cell transplant</topic><topic>Female</topic><topic>graft failure</topic><topic>Graft rejection</topic><topic>Graft Rejection - diagnosis</topic><topic>Graft Rejection - therapy</topic><topic>Graft Survival - physiology</topic><topic>Grafts</topic><topic>graft‐versus‐host disease</topic><topic>haploidentical transplant</topic><topic>Hematopoietic stem cells</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Peripheral blood</topic><topic>Peripheral Blood Stem Cell Transplantation - methods</topic><topic>Peripheral Blood Stem Cell Transplantation - trends</topic><topic>peripheral blood stem cells</topic><topic>Salvage Therapy - methods</topic><topic>Salvage Therapy - trends</topic><topic>Sepsis</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Transplantation, Haploidentical - methods</topic><topic>Transplantation, Haploidentical - trends</topic><topic>Transplants &amp; implants</topic><topic>Treatment Failure</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kliman, David</creatorcontrib><creatorcontrib>Bilmon, Ian</creatorcontrib><creatorcontrib>Kwan, John</creatorcontrib><creatorcontrib>Blyth, Emily</creatorcontrib><creatorcontrib>Micklethwaite, Ken</creatorcontrib><creatorcontrib>Panicker, Shyam</creatorcontrib><creatorcontrib>Bhattacharyya, Abir</creatorcontrib><creatorcontrib>Deren, Stephanie</creatorcontrib><creatorcontrib>Antonenas, Vicki</creatorcontrib><creatorcontrib>Huang, Gillian</creatorcontrib><creatorcontrib>Gottlieb, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Internal medicine journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kliman, David</au><au>Bilmon, Ian</au><au>Kwan, John</au><au>Blyth, Emily</au><au>Micklethwaite, Ken</au><au>Panicker, Shyam</au><au>Bhattacharyya, Abir</au><au>Deren, Stephanie</au><au>Antonenas, Vicki</au><au>Huang, Gillian</au><au>Gottlieb, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single‐centre case series</atitle><jtitle>Internal medicine journal</jtitle><addtitle>Intern Med J</addtitle><date>2018-08</date><risdate>2018</risdate><volume>48</volume><issue>8</issue><spage>988</spage><epage>991</epage><pages>988-991</pages><issn>1444-0903</issn><eissn>1445-5994</eissn><abstract>Graft failure affects approximately 5% of allogeneic stem cell transplants, with a poor prognosis. Salvage second allogeneic stem cell transplantation (alloSCT2) is limited by high rates of transplant‐related mortality from infection and graft‐versus‐host disease. We report on five adult patients receiving rescue alloSCT2 using haploidentical peripheral blood stem cells. All patients achieved neutrophil engraftment, two subsequently died from sepsis and disease relapse, respectively. Three patients remain alive up to 2 years post‐transplant. We suggest consideration of haploidentical alloSCT2 for patients with graft failure.</abstract><cop>Melbourne</cop><pub>John Wiley &amp; Sons Australia, Ltd</pub><pmid>30133987</pmid><doi>10.1111/imj.13979</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-2020-0275</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1444-0903
ispartof Internal medicine journal, 2018-08, Vol.48 (8), p.988-991
issn 1444-0903
1445-5994
language eng
recordid cdi_proquest_miscellaneous_2092537729
source Wiley Online Library - AutoHoldings Journals; MEDLINE
subjects Adult
allogeneic stem cell transplant
Female
graft failure
Graft rejection
Graft Rejection - diagnosis
Graft Rejection - therapy
Graft Survival - physiology
Grafts
graft‐versus‐host disease
haploidentical transplant
Hematopoietic stem cells
Humans
Male
Middle Aged
Peripheral blood
Peripheral Blood Stem Cell Transplantation - methods
Peripheral Blood Stem Cell Transplantation - trends
peripheral blood stem cells
Salvage Therapy - methods
Salvage Therapy - trends
Sepsis
Stem cell transplantation
Stem cells
Transplantation, Haploidentical - methods
Transplantation, Haploidentical - trends
Transplants & implants
Treatment Failure
Young Adult
title Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single‐centre case series
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A06%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rescue%20haploidentical%20peripheral%20blood%20stem%20cell%20transplantation%20for%20engraftment%20failure:%20a%20single%E2%80%90centre%20case%20series&rft.jtitle=Internal%20medicine%20journal&rft.au=Kliman,%20David&rft.date=2018-08&rft.volume=48&rft.issue=8&rft.spage=988&rft.epage=991&rft.pages=988-991&rft.issn=1444-0903&rft.eissn=1445-5994&rft_id=info:doi/10.1111/imj.13979&rft_dat=%3Cproquest_cross%3E2084620781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2084620781&rft_id=info:pmid/30133987&rfr_iscdi=true